Tribunal remits tax issues for fresh review, addresses errors, and partially allows appeal.

The Tribunal set aside the lower authorities' orders and remitted the issues to the Transfer Pricing Officer and Assessing Officer for fresh adjudication, instructing them to address the identified errors and adhere to the Tribunal's observations. The appeal was partly allowed for statistical purposes.

---

---

Issues Involved:

1. Transfer Pricing (TP) Adjustment towards Location Savings.
2. Treatment of Alleged Location Savings as an International Transaction.
3. Methodology for Determining Arm's Length Price (ALP) under Section 92C(1).
4. Presumption of Location Savings Advantage Accruing to the Appellant.
5. Consideration of Location Savings in Comparable Companies' Margins.
6. Computation Errors in Adjustment on Account of Location Savings.
7. Adjustment on Account of Recovery of Expenses (Investigator's Fee) from Associated Enterprises (AEs).
8. Application of Mark-up on Investigator Fees Recovered.

Issue-wise Detailed Analysis:

1. Transfer Pricing (TP) Adjustment towards Location Savings:

The TP adjustment towards location savings amounting to Rs. 21,69,17,701 was challenged. The TPO alleged that conducting clinical trials in India resulted in location savings for AEs due to lower regulatory and investigatory costs compared to developed countries. The TPO relied on a non-contemporaneous article to compute location savings and proposed an adjustment by splitting the alleged savings between the AE and the appellant.

2. Treatment of Alleged Location Savings as an International Transaction:

The appellant argued that the alleged location savings should not be treated as an international transaction under Section 92B of the Act. The Tribunal previously held that location savings are relevant for cross-border transactions but should not be the sole basis for determining ALP. The Tribunal emphasized that location savings should be considered only for examining and investigating transactions, not for direct ALP adjustments.

3. Methodology for Determining Arm's Length Price (ALP) under Section 92C(1):

The appellant contended that the TPO did not follow any prescribed method under Section 92C(1) for determining ALP. The Tribunal concurred, noting that the TPO's computation was based on presumptions and non-verified articles rather than actual data. The Tribunal directed the TPO/AO to re-examine and adjudicate the issue afresh using proper comparability analysis and reliable data.

4. Presumption of Location Savings Advantage Accruing to the Appellant:

The appellant argued that the TPO and DRP erred in presuming that location savings advantage accrues to the appellant. The Tribunal noted that location savings are available to all parties in a competitive market and should not be presumed to confer unique advantages to the appellant. The Tribunal directed the TPO/AO to re-evaluate the functional comparability of companies selected by the appellant.

5. Consideration of Location Savings in Comparable Companies' Margins:

The appellant argued that location savings, if any, are already embedded in the margins of comparable companies considered for benchmarking. The Tribunal agreed, stating that if local comparables are available, the benefits of location savings are captured in the ALP determined. The Tribunal directed the TPO/AO to consider this aspect while re-evaluating the issue.

6. Computation Errors in Adjustment on Account of Location Savings:

The appellant highlighted several computation errors by the TPO, including reliance on unverified information, non-contemporaneous data, and incorrect use of the Profit Split Method. The Tribunal found merit in these arguments and directed the TPO/AO to rectify these errors during re-adjudication.

7. Adjustment on Account of Recovery of Expenses (Investigator's Fee) from Associated Enterprises (AEs):

The TPO made an adjustment of Rs. 5,45,30,838 on account of recovery of expenses (investigator's fee) from AEs, applying a mark-up of 15.27%. The appellant argued that these were pass-through costs reimbursed on a cost-to-cost basis without any profit element. The Tribunal noted that the appellant acted as a coordinator and facilitator, and the entire risk of clinical trials was borne by the AEs and third-party investigators.

8. Application of Mark-up on Investigator Fees Recovered:

The Tribunal observed that the appellant received a mark-up on its internal costs for coordination and facilitation activities. However, the TPO's imposition of a mark-up on pass-through costs was deemed inappropriate. The Tribunal directed the TPO/AO to exclude pass-through costs from the mark-up computation and consider only the value-added costs incurred by the appellant.

Conclusion:

The Tribunal set aside the orders of the lower authorities and remitted the issues to the TPO/AO for fresh adjudication, directing them to follow the Tribunal's observations and rectify the identified errors. The appeal was partly allowed for statistical purposes.

---